Clinical Trial Update: Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating N-acetylcysteine for systemic lupus erythematosus. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: ACTIVE_NOT_RECRUITING